| |
|
|
|
Oasmia Pharmaceutical AB (publ)  
|
|
3.27 -0.09 (-0.03%) |
12-13 16:00 |
|
Open: |
3.4 |
Pre close: |
3.36 |
Target:
|
5.07
|
|
High: |
3.44 |
Low: |
3.27 |
Resistance:
|
4.34
5.10
|
|
Volume: |
2,897 |
Market Cap: |
225M |
Support:
|
3.11
2.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.37
 |
MACD |
MACD(12,26):
|
-0.26 |
|
MA(20): |
4.09 |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
3.23  |
Stochastic Oscillator |
%K(14,3):
|
16.88 |
|
MA(250): |
2.11 |
%D(3): |
13.53 |
|
Average Volume(K) |
3-Month: |
7450
|
52-Week |
High:
|
5.70 |
|
10-Days: |
1555 |
Low: |
0.85 |
|
RSI |
RSI(14):
|
38.83 |
Change(%): |
227.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-38.6 |
Shares Out. (M) |
59.77 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-26.3 |
Shares Float (M) |
59.77 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
15.9 |
% Held by Institutions |
0.10 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.630 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.55 |
P/S |
36332969984.00 |
|
Operating Margin |
-813.76 |
Levered Free Cash Flow
(M) |
-14.19 |
P/CF |
-16.92 |
|
|
|
|
|
|
